| Financial Year |
March 31 2023 |
| Monetary Funds |
758,954,034.36 |
| Held-for-trading Financial Assets |
95,455,001.06 |
| Notes Receivable |
9,283,451.30 |
| Accounts Receivable |
1,551,113,018.21 |
| Advances to Suppliers |
233,114,340.91 |
| Other Receivables |
17,324,223.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
990,466,722.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
147,636,683.28 |
| Total Current Assets |
4,678,565,517.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,540,348,321.56 |
| Under-construction Projects |
1,051,055,081.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,918,633.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
123,798,410.67 |
| Deferred Income Tax Assets |
107,803,140.90 |
| Other Non-Current Assets |
121,844,899.19 |
| Sub-Total of Non-Current Assets |
3,234,559,760.08 |
| Total Assets |
7,913,125,277.40 |
| Short-Term Loans |
1,491,381,532.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,292,458,362.83 |
| Accounts Payable |
723,145,103.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
78,949,150.80 |
| Taxes Payable |
20,531,348.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,984,513.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
520,839,032.18 |
| Other Current Liabilities |
12,998,222.57 |
| Sub-Total of Current Liabilities |
4,215,404,422.73 |
| Long-term Loans |
1,099,677,908.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
39,599,344.96 |
| Deferred Income Tax Liabilities |
24,916,359.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,282,683,429.51 |
| Total Liabilities |
5,498,087,852.24 |
| Paid-In Capital(Or Share Stock) |
102,782,850.00 |
| Capital Surplus |
1,685,304,921.21 |
| Surplus Reserve |
65,578,058.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
561,371,595.48 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,415,037,425.16 |
| Owner's Equity（Stockholder's Equity） |
2,415,037,425.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,913,125,277.40 |
